Overexpression of Claudin Proteins in Esophageal Adenocarcinoma and Its Precursor Lesions
- 1 March 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 14 (1) , 24-30
Abstract
Claudins are components of tight junctions important in intercellular barriers and cell polarity. The authors identified upregulation of Claudins 3, 4, and 7 in gastric adenocarcinoma using Affymetrix U-133 oligonucleotide microarrays and immunohistochemistry (IHC). While normal gastric mucosa lacked Claudin 3, 4, and 7 expression, intestinal metaplasia and dysplasia showed these proteins. The authors hypothesized that Claudins would be similarly overexpressed in Barrett's esophagus (BE)/adenocarcinoma. Claudins 3, 4, and 7 gene expression was analyzed by Affymetrix U-133 microarrays in three esophageal adenocarcinomas, one case of BE, and three normal esophagi. IHC validation was performed using tissue microarrays constructed from esophageal resection specimens containing squamous (44 cases), gastric (40 cases), and nondysplastic BE (16 cases), low-grade and high-grade dysplasia (16 and 26 cases), adenocarcinoma (58 cases), and nodal metastases (27 cases). IHC staining was scored semiquantitatively (0+ to 4+). By microarray analysis, Claudin 3 showed a marked increase in mRNA expression compared with normal esophagus (approximately 100-fold). Claudins 4 and 7 were modestly increased (2.2- and 1.3-fold). By IHC, Claudin 3 expression was 1+ in most (>95%) normal squamous or gastric tissues and 2+ to 4+ in more than 80% of high-grade dysplasia, adenocarcinoma, and metastases specimens. Claudin 4 protein expression was 2+ or less in most squamous and gastric mucosa (>90%) but 3+ or 4+ in BE, low- and high-grade dysplasia, adenocarcinoma, and metastases specimens (>90%). Claudin 7 expression was minimal in squamous and gastric mucosa but strong (3+ to 4+) in BE and low-grade dysplasia. In high-grade dysplasia, adenocarcinoma, and metastases, Claudin 7 was less intense, with 60% to 70% staining 3+ or 4+ and 30% to 40% staining weakly (1+ or 2+). The findings suggest that alterations in Claudin proteins are an early event in tumorigenesis and may provide targets for diagnosis and directed therapy for esophageal adenocarcinoma and its precursors.Keywords
This publication has 24 references indexed in Scilit:
- Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breastOncogene, 2003
- Epidemiologic trends in esophageal and gastric cancer in the United StatesSurgical Oncology Clinics of North America, 2002
- Claudin-4: A new target for pancreatic cancer treatment using Clostridium perfringens enterotoxinGastroenterology, 2001
- Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmationHuman Pathology, 2001
- Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal AdenocarcinomaNew England Journal of Medicine, 1999
- Claudin multigene family encoding four-transmembrane domain protein components of tight junction strandsProceedings of the National Academy of Sciences, 1999
- Changing patterns in the incidence of esophageal and gastric carcinoma in the United StatesCancer, 1998
- Determination of Functional Regions ofClostridium perfringensEnterotoxin Through Deletion Analysis.Clinical Infectious Diseases, 1997
- Molecular Cloning and Functional Characterization of the Receptor for Clostridium perfringens EnterotoxinJournal of Cell Biology, 1997
- Interferon pretreatment enhances the sensitivity of Vero cells to Clostridium perfringens type A enterotoxinMicrobial Pathogenesis, 1987